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Abstract
Telomeres are nucleoprotein complexes that protect the ends of linear chromosomes from
incomplete replication, degradation and detection as DNA breaks. Mammalian telomeres
are protected by shelterin, a multiprotein complex that binds the TTAGGG telomeric repeats
and recruits a series of additional factors that are essential for telomere function. Although
many shelterin-associated proteins have been so far identified, the inventory of shelterin-in-
teracting factors required for telomere maintenance is still largely incomplete. Here, we
characterize AKTIP/Ft1 (human AKTIP and mouse Ft1 are orthologous), a novel mammali-
an shelterin-bound factor identified on the basis of its homology with the Drosophila telo-
mere protein Pendolino. AKTIP/Ft1 shares homology with the E2 variant ubiquitin-
conjugating (UEV) enzymes and has been previously implicated in the control of apoptosis
and in vesicle trafficking. RNAi-mediated depletion of AKTIP results in formation of telomere
dysfunction foci (TIFs). Consistent with these results, AKTIP interacts with telomeric DNA
and binds the shelterin components TRF1 and TRF2 both in vivo and in vitro. Analysis of
AKTIP- depleted human primary fibroblasts showed that they are defective in PCNA recruit-
ing and arrest in the S phase due to the activation of the intra S checkpoint. Accordingly,
AKTIP physically interacts with PCNA and the RPA70 DNA replication factor. Ft1-depleted
p53-/- MEFs did not arrest in the S phase but displayed significant increases in multiple telo-
meric signals (MTS) and sister telomere associations (STAs), two hallmarks of defective
telomere replication. In addition, we found an epistatic relation for MST formation between
Ft1 and TRF1, which has been previously shown to be required for replication fork progres-
sion through telomeric DNA. Ch-IP experiments further suggested that in AKTIP-depleted
cells undergoing the S phase, TRF1 is less tightly bound to telomeric DNA than in controls.
Thus, our results collectively suggest that AKTIP/Ft1 works in concert with TRF1 to facilitate
telomeric DNA replication.
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Author Summary
Chromosome ends are capped by specialized structures called telomeres, which protect
chromosomes from deterioration, incomplete replication and end-to-end fusion. Defects
in telomere structure and/or function may have a strong impact on human health, leading
to premature aging and a variety of diseases including cancer. One of the most important
tasks to understand and possibly prevent the consequences of telomere dysfunction is the
identification and characterization of telomere-associated proteins. Here we show for the
first time that human telomeric proteins can be identified on the basis of their homology
with those that protect the telomeres of the fruit fly Drosophila melanogaster. Although
flies and humans elongate their telomeres through different mechanisms, our studies sug-
gested that a subset of Drosophila telomere-associated proteins have conserved human
counterparts. Based on this hypothesis we identified and characterized a novel human
telomeric protein called AKTIP. We show that AKTIP binds the components of the shel-
terin multiprotein complex, which caps and protects the human telomeres. AKTIP-deplet-
ed chromosomes exhibit an accumulation of DNA repair factors at their ends (telomere
dysfunction foci), which are diagnostic of telomere damage. Loss of AKTIP results in a
general impairment of DNA synthesis and in defective telomere replication. Collectively,
our results indicate that AKTIP cooperates with the shelterin component TRF1 to ensure
proper telomere replication.
Introduction
Mammalian telomeres consist of double stranded TTAGGG repeats that terminate with a sin-
gle stranded 3' overhang. These repeats are added to chromosome ends by telomerase to com-
pensate for the terminal DNA loss that occurs at each replication cycle due to the intrinsic
inability of the DNA replication machinery to duplicate chromosome ends [1]. The TTAGGG
repeats bind a telomere-specific six-subunit protein complex, called shelterin, that inhibits the
DNA damage response (DDR) at chromosome ends and regulates telomerase activity [2].
Three of the shelterin subunits directly interact with the TTAGGG repeats; TRF1 and TRF2
bind the TTAGGG duplex, and POT1 binds the 3’ overhang. TRF1, TRF2 and POT1 are inter-
connected by TIN2 and TPP1, and TRF2 interacts with hRap1, a distant homologue of S. cere-
visiae Rap1 [2].
Although the shelterin components form a complex, deletions of individual shelterin sub-
units result in different phenotypes. For example, deletion of TRF2 activates ATM signaling
and the Non Homologous End Joining (NHEJ) DNA repair pathway leading to telomeric fu-
sions (TFs). NHEJ-induced TFs are also observed in POT1- or TPP1-depleted cells, but in this
case following activation of the ATR kinase [2–5]. In contrast, loss of TRF1 activates ATR/
ATM signaling and disrupts telomere replication [6, 7].
The shelterin subunits interact with several conserved polypeptides, often called shelterin
accessory factors [2], which are also required for proper telomere function. These polypeptides
include many proteins involved in the DNA damage response and in DNA repair such as the
ATM kinase, the Ku70/80 heterodimer, the MRE11-RAD50-NBS1 (MRN) complex, Rad51,
the ERCC1-XPF and MUS81 endonucleases, the Apollo exonuclease, the RecQ family mem-
bers WRN and BLM, and the RTEL1 helicase. In addition, mammalian telomeres are enriched
in Heterochromatin Protein 1 (HP1), the Ga9 histone methyltransferase, the Timeless compo-
nent of the replisome, and the subunits of the conserved ORC and CST complexes. Losses of
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these shelterin accessory factors result in diverse telomere phenotypes ranging from defective
telomere replication, telomere shortening, telomere loss and telomere fusion [2, 8–12].
A peculiar phenotype observed after loss of specific shelterin components or shelterin acces-
sory factors are multiple telomeric signals (MTSs), also dubbed fragile telomeres. MTSs can be
observed after fluorescent in situ hybridization (FISH) with TTAGGG probes and consist of
two or more signals associated with an individual chromatid end, which normally exhibits a
single compact FISH signal. MTSs have been observed after loss of several telomere-associated
factors including TRF1 [6, 7] the BLM and RTEL1 helicases [6, 13], the Apollo nuclease [14–
16], topoisomerase 2α (Top2α) [17], the Timeless replication factor [11], and the components
of the mammalian CTC1-STN1-TEN1 (CST) complex [12, 18, 19]. Strong evidence indicates
that MTSs are caused by defective telomere replication and it has been suggested that they are
caused by problems in replication fork progression through telomeric DNA [6, 17–19].
We have recently identified pendolino (peo), a Drosophila gene that encodes an E2 variant
enzyme required to prevent telomere fusion [20]. Peo interacts with terminin, a non-conserved
Drosophila telomere-capping complex that is functionally analogous to shelterin [21–23]. Here
we asked whether the human and mouse homologues (AKTIP and Ft1) of Drosophila Peo are
required for telomere maintenance. We show that AKTIP/Ft1 is in fact needed for telomeric
DNA replication and that it interacts with telomeric DNA, shelterin, and PCNA. These find-
ings support the hypothesis [22] that “terminin accessory factors” are evolutionarily conserved
proteins whose homologues might play telomere-related functions in mammals.
Results
AKTIP depletion affects cell cycle progression and induces the DDR and
TIFs
To determine the roles of the mammalian homologues of Drosophila Peo (AKTIP in humans
and Ft1 in mice), we produced AKTIP- and Ft1-depleted cells by lentivirus-mediated RNA in-
terference. We generated five different hairpin sequences directed against AKTIP and three
against Ft1. Infection of human primary fibroblasts (HPFs) or mouse embryonic fibroblasts
(MEFs) with these recombinant lentivectors (LV-shAKTIP and LV-shFt1; henceforth abbrevi-
ated as shAKTIP and shFt1) resulted in target mRNA reductions to less than 13% of the wild
type levels as measured by Q-PCR (S1A and S1B Fig). Comparable target protein reductions
were observed by Western blotting in the same cells as well as in HeLa and 293T cells (S1C
Fig). If not otherwise specified, in the experiments described below, we used shAKTIP11 and
shFt170 infected cells (S1 Fig); uninfected cells (mock) or cells infected with a vector containing
a scrambled sequence (ctr) were used as controls.
10 days post infection (dpi) with shAKTIP, HPFs from healthy individuals displayed a
strong reduction in the mitotic index compared to controls (Fig 1A); this reduction was accom-
panied by a 12 to 18 fold increase in cyclin A levels, and a more modest increase in cyclin E
(Fig 1B), indicating a block/delay in cell cycle progression during late S or G2 phases. Analyses
of population doubling in shAKTIP-infected HPFs, 293T and HeLa cells showed that only the
HPFs are strongly susceptible to AKTIP down-regulation (Fig 1C), suggesting that AKTIP de-
pletion blocks the cell cycle by triggering p53- and pRb-dependent checkpoints, which are
compromised in 293T and HeLa cells.
The AKTIP-dependent proliferation block is a likely consequence of the DNA damage re-
sponse (DDR), as the phosphorylation levels of the DDR effectors ATM, Chk1 and p53 [24]
were higher in shAKTIP HPFs than in controls (Fig 1D). The observation that the Chk1 phos-
phorylation level is substantially higher than that of ATM strongly suggests that in AKTIP-de-
pleted cells there is a specific upregulation of the ATR/Chk1 pathway. AKTIP-depleted HPFs
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Fig 1. AKTIP depletion affects cell cycle progression and induces the DNA damage response (DDR). (A) Relative mitotic indexes (± SD) of shAKTIP
(hairpin sequences 9, 11 and 13) and control (ctr) at 10 dpi. (B) Immunoblotting of 10 dpi extracts from shAKTIP HPFs shows accumulation of cyclins
compared to ctr; in the graph, blot signals are normalized relative to the actin used as a loading control. (C) Cumulative population doublings of HPFs, HeLa
and 293T cells transduced with ctr or shAKTIP-11. (D) Immunoblots of 10 dpi extracts reveal DNA damage signaling in shAKTIP samples. Densitometric
analysis showed that in 9, 11 and 13 RNAi cells there is a 2.7-, 2.6-, and 3.3-fold increase of Chk1, respectively; in the same cells ATM-P Ser 1981 increases
were 1.4-, 1.6- and 2.0-fold, respectively. (E) Q-PCR of total RNA shows a strong increase in p21 expression in shAKTIP-11 HPFs relative to control;
samples collected at 7 dpi were analyzed in duplicate and shown as mean values ± SD. See also S1 Fig.
doi:10.1371/journal.pgen.1005167.g001
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also showed an ~ 8 fold increase in p21 mRNA relative to controls (Fig 1E); p21 is a p53 direct
transcriptional target that negatively regulates cell cycle by inhibiting cyclin-dependent kinase
[25].
AKTIP depletion induces TIFs
Consistent with the DDR activation, AKTIP-depleted HPFs displayed abundant DNA repair
foci containing γH2AX, 53BP1 and phosphorylated ATM (at S1981; abbreviated with ATM-P)
(Fig 2A and 2B); the frequency of AKTIP RNAi cells with at least 5 nuclear foci was significant-
ly higher than that observed in controls (Fig 2C). γH2AX, 53BP1 and ATM-P co-localized at
most foci suggesting a coordinated response, comparable to that induced by exogenous X ray-
induced DNA damage (S2 Fig).
To detremine whether the DNA repair foci seen in AKTIP RNAi HPFs are Telomere dys-
function-Induced Foci (TIFs, [26]), we immunostained the cells with both anti-TRF1 and anti-
γH2AX antibodies. We found frequent co-localization of TRF1 and γH2AX signals (~50%),
which was significantly higher than that observed in irradiated cells, where>80% of the
γH2AX signals did not co-localize with telomeres (Fig 2D and 2E). TRF1 and γH2AX co-stain-
ing also verified that>60% of the AKTIP-depleted cells display more than 5TIFs/cell (Fig 2E).
Contradictory data on the existence of a biochemical link between the AKT kinase and
AKTIP have been previously reported [27, 28]. We thus asked whether AKT has a role in telo-
mere maintenance. At 10 dpi with an AKT-interfering lentivector (S3 Fig), HPFs did not dis-
play an increase in 53BP1 foci compared to controls, suggesting that AKT is not required for
telomere stability (Fig 2F and 2G).
AKTIP depletion results in fragile telomeres
Given that AKTIP RNAi HPFs exhibit a very low mitotic index, to determine the telomere phe-
notype generated by AKTIP depletion we used p53-/- MEFs (henceforth designated as MEFs),
which do not undergo a cell cycle arrest following DNA damage or telomere attrition [5]. Telo-
meric FISH showed that 7 dpi shFt1 MEFs exhibit a significant increase in the proportion of
chromatid ends with multiple telomeric signals (MTSs) with respect to controls (Fig 3A and
3B). MTSs, also dubbed fragile telomeres, have been previously observed in several settings and
strong evidence exists that they are generated by defects in telomeric DNA replication [6, 15,
18, 19].
The frequency of telomeric FISH signals in Ft1-RNAi MEFs (95.9%) was not significantly
different from those of mock (93.6%) and ctr (94.6%) controls (S4A Fig). In addition, Southern
blotting analysis showed that the average length of telomeric DNA fragments from shAKTIP-
transduced HPFs was comparable to that of untreated cells (S4B Fig). Thus, AKTIP depletion
does not appear to cause abrupt telomere erosion. Consistent with these results, Ft1-depleted
MEFs showed only a small and nonsignificant increase in TFs with respect to controls (Fig 3B).
However, Ft1 RNAi MEFs displayed a significantly higher frequency of sister telomere associa-
tions (STAs) than control cells (Fig 3A and 3B). These associations always showed a strong
FISH signal at the STA site. STAs have been previously observed in telomere replication defec-
tive cells; it has been proposed that STAs are not genuine TFs generated by the DNA repair ma-
chinery but are instead the consequence of DNA bridging induced by replication stress [6, 17].
Previous studies have shown that loss of TRF1 impairs telomere replication resulting in
both MTSs and STAs [6, 7]. We thus asked whether Trf1 and Ft1 function in the same path-
way. The frequencies of MTSs in Trf1- or Ft1-deficient cells were comparable, and not signifi-
cantly different from that observed in cells codepleted of both proteins (Fig 3C; see S5 Fig for
codepletion levels). Interestingly, Trf1 deficient cells and cell co-depleted of both Trf1 and Ft1
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Fig 2. AKTIP downregulation induces TIF formation. (A) γH2AX (green in merges), ATM-P (red in merges) and 53BP1 (red in merges) foci in 5 dpi
shAKTIP-11 HPFs. Foci are absent in mock and 5 dpi ctr HPFs. (B, C) Numbers of foci per cell (B) and percents of cells with more than 5 foci (C); bars are the
mean values from two independent experiments ± SD. (D) TIFs in 5 dpi shAKTIP-11 HPFs (in merges, γH2AX is green and TRF1 red); arrowheads point to
TIFs. X-ray-treated (IR; 1 Gy) HPFs were used as controls. (E) Percents of γH2AX foci co-localizing with TRF1 (TIFs), and of cells with more than 5 TIFs.
Bars are the mean values from two independent experiments ± SD. ***, **, * indicate p<0.001 p<0.01 p<0.05 in the Student t test, respectively. See also S2
and S3 Figs. (F-G) Depletion of the AKT kinase does not induce formation of 53BP1 DNA repair foci. (F) Examples of 53BP1 foci in mock, ctr, and shAKT
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showed an STA frequency significantly higher than that seen in cells lacking only Ft1 (Fig 3B
and 3C). These results suggest an epistatic relationship between Trf1 and Ft1 for MTS forma-
tion. However, the relationship between these genes in STA formation is less clear. Our results
only indicate that MTS and STAs arise from different forms of stress or are repaired in a
different manner.
We also examined the MTS pattern in Ft1-, Trf1- and Ft1+ Trf1- depleted cells. For this
analysis we pooled the data shown in Fig 3B and 3C. In control (both mock and ctr) and
Ft1-depleted cells, the frequency of MTSs involving both sister telomeres was significantly
higher than that expected for independent events (Fig 3D and 3E). This finding indicates that
both in control and Ft1 deficient cells the leading- and lagging-strand telomeres are equally
susceptible to DNA replication problems, and further suggests that at least a fraction of the
HPFs. (G) Quantification of 53BP1 foci in mock, ctr, and shAKT HPFs. 100 cells scored for each sample. Values are the means of two independent
experiments ± SD, and are not significantly different in the Student t test.
doi:10.1371/journal.pgen.1005167.g002
Fig 3. Ft1 downregulation leads to telomeric aberrations. (A) Partial DAPI-stained (red) metaphases from ctr or shFt1 MEFs showing telomeric FISH
signals (black and white; green in merges); arrows indicate selected multiple telomeric signals (MTSs), and arrowhead points to sister telomere associations
(STAs). (B) MTS, STA and telomere fusion (TF) frequencies in mock and 7 dpi ctr and shFt1 MEFs; *** significantly different from controls in the χ2 test with
p<0.001. Values are the mean frequencies from 2 independent experiments. (C) Trf1 is epistatic to Ft1. The MTS frequencies observed in shFt1, shTrf1 and
shFt1 + shTrf1 are not significantly different in the χ2 test, but the STA frequencies observed in shFt1, shTrf1 and shFt1 + shTrf1 are significantly higher that
that seen shFt1 (***different in the χ2 test with p<0.001). Values are the mean frequencies from 2 independent experiments. (D) Relative frequencies of the
indicated chromosome types; frequencies were calculated from pooled data (B and C). (E) Observed (O) and expected (E; on the basis of independence;
calculated from pooled data using the binomial distribution formula) frequencies of sister telomere pairs with the indicated FISH patterns; ***O-E differences
significant with p<0.001 in the χ2 test. See also S4 and S5 Figs.
doi:10.1371/journal.pgen.1005167.g003
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MTSs observed in these cells is generated by events that simultaneously impair replication of
both DNA strands. In Trf1 depleted cells, the frequency of MTSs involving both sister telo-
meres was not significantly different from that expected for independent events (Fig 3D and
3E). The finding that doubly depleted cells did not display a significant difference between the
observed and the expected frequencies of MTSs at both sister telomeres suggests that Trf1 is ep-
istatic to Ft1, (Fig 3D and 3E). However, we cannot envisage a mechanistic explanation for the
formation of an excess of fragile sister telomeres in both control and Ft1-depleted cells but not
in Trf1-deficient cells.
AKTIP interacts with telomeres
The telomeric phenotype observed in AKTIP/Ft1 depleted cells, prompted us to investigate
whether AKTIP interacts with telomeric DNA and the shelterin complex. We used chromatin
IP (ChIP) to ask whether AKTIP interacts with telomeric DNA of wild type HPFs. Hybridiza-
tion with a [TTAGGG]n probe showed the presence of telomeric DNA in samples immunopre-
cipitated with an anti-AKTIP antibody (Fig 4A and 4B). A clear interaction between AKTIP
and telomeric DNA was also detected in HeLa cells. The specificity of this interaction is sub-
stantiated by the absence of a detectable interaction between AKTIP and ALU DNA (in both
HPFs and HeLa cells), and by the significant reduction of telomeric DNA in precipitates from
AKTIP-depleted HeLa cell extracts (Fig 4A and 4B).
Fig 4. AKTIP interacts with telomeric DNA, TRF1 and TRF2. (A) ChIPs from HPFs, uninfected HeLa cells and shAKTIP-11-infected HeLa cells reveal
interactions between AKTIP and telomeric DNA. Chromatin was immunoprecipitated with an anti-AKTIP antibody or control IgGs; slot-blots were hybridized
with TTAGGG or ALU repeat probes. (B) ChIP quantification after normalization to the input (levels shown in A). Bars show the mean values of two
experiments ± SD; the amount of telomeric DNA precipitated from uninfected HeLa cells is significantly higher than that obtained from shAKTIP-11-infected
cells (*p<0.05 in the Student t test). (C, D) AKTIP-GST pulls down TRF1 (C) and TRF2 (D) from 293T cell extracts. In, input; M, MWmarkers.
doi:10.1371/journal.pgen.1005167.g004
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To determine whether AKTIP interacts with TRF1 and TRF2 we performed GST pulldown
experiments from cells extracts. We found that a GST-AKTIP fusion protein precipitates both
TRF1 and TRF2 from 293T cell extracts (Fig 4C and 4D).
AKTIP directly binds TRF1 and TRF2
Previous studies have classified AKTIP as an E2 variant (UEV) enzyme [29]. UEVs are similar
to E2 ubiquitin conjugating enzymes (UBCs) but lack the catalytic cysteine residue that is criti-
cal for the transient interaction between ubiquitin and E2. We performed a bioinformatic anal-
ysis to elaborate a three-dimensional model of AKTIP and compared this model with that of
Peo, the AKTIP/Ft1 Drosophila orthologue required for telomere protection [20]. As shown in
Fig 5A and S6 Fig, a structural comparison between the AKTIP and Peo models shows that the
core UEV domains of these proteins are very similar. AKTIP and Peo, like all E2 proteins,
share a canonical “core” ubiquitin-conjugating (UBC) domain of ~150 amino acids, composed
of a four stranded, anti-parallel curled β-sheet. AKTIP and Peo possess additional N- and C-
terminal sequences, which could be involved in regulatory functions and/or specific interac-
tions with other macromolecules [29]. In AKTIP, the α-helices are present only on three sides
of the UEV domain, while the UEV core of Peo is surrounded on four sides by α-helical seg-
ments. However, the most relevant structural difference between AKTIP and Peo is the addi-
tional N-teminal disordered region predicted only in AKTIP but lacking in Peo.
Based on the AKTIP 3D model, we constructed three protein truncations, which together
define the main AKTIP structural elements (Fig 5B). GST pulldown analysis with bacterially
purified proteins showed that TRF1 and TRF2 directly bind the AKTIP UEV domain but not
Fig 5. AKTIP directly binds TRF1 and TRF2. (A) A tridimensional molecular model for AKTIP. The arrows point to the starting sites of the disordered N- and
C-terminal regions (not depicted); the variant Asp residue and His-Pro-Leu motif are represented as sticks and indicated by red and purple arrows,
respectively (see also S5 Fig). (B) Schematic organization of the AKTIP protein; the AKTIP truncations used for GST pulldown are indicated below the
scheme. (C, D) In vitro mapping the AKTIP regions that interact with TRF1 or TRF2 using bacterially purified proteins; the UEV domain of AKTIP binds both
TRF1 and TRF2.
doi:10.1371/journal.pgen.1005167.g005
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the C-terminal helices or the disordered regions at both termini of the protein (Fig 5C and 5D
and S6 Fig). These findings, together with the results of GST pulldown from cell extracts (Fig
4), indicate that AKTIP binds shelterin both in vivo and in vitro.
AKTIP is required for general DNA replication and interacts with
replisome components
The fragile telomere phenotype observed in AKTIP-depleted cells suggests that AKTIP could
function in DNA replication. We thus analyzed the cell cycle distribution of unsynchronized
10 dpi shAKTIP HPFs. Flow cytometry analysis of BrdU/Propidium iodide (PI)-stained cells
revealed that in shAKTIP-infected cultures 55% of the cells exhibit an S phase DNA content,
40% a G1 content and 5% a G2/M content. Only 9% of the cells showed both an S phase DNA
content and BrdU incorporation, while in the remaining S phase cells (46% of the total) BrdU
incorporation was not detectable. In 10 dpi control (ctr) HPFs, the S phase cells with normal
BrdU incorporation were 26% of the total, the G1 cells 57% and the G2/M cells 16%; the fre-
quency of cells with an S phase DNA content and no BrdU incorporation was only 1% (Fig
6A). These findings suggest that the cells that do not incorporate BrdU and whose DNA con-
tent is intermediate between G1 and G2 are blocked in S phase by an intra-S checkpoint trig-
gered by DNA replication defects elicited by lack of AKTIP (see also Fig 1 above).
With these results in mind, we examined the distribution of PCNA (proliferating cell nucle-
ar antigen) in AKTIP-depleted and control HPF nuclei. PCNA is a homotrimeric complex that
encircles the DNA at the site of synthesis, acting as a processivity factor for DNA polymerases
[30, 31]. As positive controls we used cells treated with hydroxyurea (HU) or aphidicolin
(APC), which are known to cause cell cycle blockage in early S phase. PCNA is present in nu-
clei both in a soluble form that can be extracted by detergent treatment and in a detergent-re-
sistant form (or chromatin-bound form) that is loaded onto DNA replication forks [32]. In
unextracted nuclei, nearly 100% of control, AKTIP-depleted, HU-treated or APC-treated nu-
clei showed a PCNA signal (Fig 6B and 6C). In contrast, after Triton X-100 extraction, 30% of
control nuclei, 9% of AKTIP-depleted nuclei, 64% of HU-treated nuclei and 80% of APC-treat-
ed nuclei displayed PCNA staining. These results indicate, as expected, that PCNA associates
with replication forks in S phase control nuclei and in the nuclei of cells arrested in early S fol-
lowing either HU or APC treatment. More importantly, our results strongly suggest that the
AKTIP-depleted HPFs that exhibit an S phase DNA content but fail to incorporate BrdU (Fig
6A) do not contain chromatin-bound PCNA.
We also analyzed PCNA localization in detergent-extracted nuclei. Previous studies have
shown that PCNA marks DNA replication foci that change their position during the S phase.
Early S is characterized by numerous small PCNA foci concentrated in the inner part of the nu-
cleus; in mid-S the PCNA foci decrease in number and move toward the nuclear periphery;
and in late S, the foci increase in size and become scattered throughout the nucleus [32, 33]. In
control HPFs, we observed distributions of PCNA foci that are fully consistent with published
results [33] and allow subdivision of the S phase nuclei into four categories (early-S, mid-S,
mid/late-S, and late-S; Fig 6D). Examination of PCNA foci in detergent-extracted nuclei re-
vealed that AKTIP-depleted cells display significantly higher proportions of nuclei in mid- and
mid/late-S than controls (Fig 6E). As expected, most of the nuclei of HU- or APC-treated cells
were found to be in early S phase. These results indicate that AKTIP-depleted S phase cells,
even if they still incorporate BrdU, tend to be delayed in their progression through the S phase
and thus accumulate in mid- and mid/late-S.
We finally asked whether AKTIP physically interacts with PCNA and RPA70, which is an-
other well-known component of the DNA replication machinery. GST pull down experiments
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Fig 6. AKTIP downregulation impairs DNA replication. (A) FACS analysis of 10 dpi ctr and shAKTIP-11 HPFs incubated with BrdU for 30 min, fixed, and
then stained for BrdU and DNA (with PI). AKTIP depletion results in an S phase block; percents of cells in different cell cycle phases are reported in the upper
right corner of each panel. (B, C) PCNA localization in unsynchronized mock, 10 dpi ctr, 10 dpi shAKTIP-11, HU-treated and APC-treated HPFs. Examples
(B) and quantification of PCNA positive nuclei (C) from unextracted or Triton X-100-extracted HPFs. Bars are the mean values ± SD of samples analyzed in
duplicate. ** and * indicate significant difference from control with p<0.01 and p<0.05 in the Student t test. (D, E) Distribution of nuclei with different S phase
PCNA staining patterns. Bars in the graph (E) are the mean values ± SD of samples analyzed in duplicate; colours in E are as in the representative images
shown in D; distributions of ctr and shAKTIP nuclei are significantly different in the Student t test with p<0.05. (F) AKTIP-GST pulls down PCNA and RPA70
from 293T cell extracts.
doi:10.1371/journal.pgen.1005167.g006
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using AKTIP-GST and 293T cell extracts revealed that AKTIP precipitates both PCNA and
RPA70 (Fig 6F). It should be noted that our bioinformatic analyses did not detect PIP or APIM
motifs in the AKTIP protein. These motifs are known to mediate contacts between PCNA and
its interacting proteins but there is also evidence that PCNA can contact partner proteins inde-
pendently of these motifs (reviewed [31]). Regardless the precise nature of the AKTIP-PCNA
interaction, our data collectively indicate that AKTIP is required for DNA synthesis, and
strongly suggest that in the absence of AKTIP human primary fibroblasts arrest in interphase
due to the activation of the S phase checkpoint.
AKTIP is required for efficient telomere replication and functions in
concert with TRF1
Altogether, the findings that loss of AKTIP/Ft1 arrests cells in the S phase and results in fragile
telomeres, and that AKTIP interacts with PCNA and RPA70 suggest that AKTIP/Ft1 is in-
volved in telomere replication. In addition, our results indicated an epistatic relationship be-
tween AKTIP and TRF1, which is also required for telomere replication [6, 7]. To address the
relationships between AKTIP and TRF1 during telomere replication we combined BrdU incor-
poration (to mark replicating DNA) and chromatin immunoprecipitation (ChIP) with anti-
TRF1 antibodies. Hela cells were synchronized with a double thymidine block and harvested at
various times after release from the G1/S block; before harvest the cells were incubated with
BrdU for 1hr. The proportions of cells in S-phase at each post-release time were determined by
FACS analysis based on BrdU incorporation (Fig 7A). An examination of the scatter plots indi-
cates that the overall DNA synthesis is delayed in AKTIP-depleted cells compared to mock
controls. In addition, as shown in Fig 7B (right panel) and 7D, the chromatin fragments immu-
noprecipitated by TRF1 at the 4.5, 6 and 9 hrs post-release times contain almost no BrdU com-
pared to controls. Because AKTIP-depleted HeLa cells do not exhibit gross proliferation
defects (Fig 1C), this finding cannot be interpreted as indicating a complete failure of telomere
replication, as this event would cause profound defects in telomere structure leading to cell
cycle arrest. Thus, the most likely interpretation is that in AKTIP-depleted cells undergoing the
S phase TRF1 is less tightly bound to telomeric DNA than in controls. This interpretation is
corroborated by the observation that in AKTIP-depleted cells arrested in early S by the double
thymidine block there is less telomere-bound TRF1 than in controls (Fig 7B and 7C). However,
at the 4.5, 6 and 9 hrs post-release times AKTIP-depleted and control cells yielded similar
amounts of TTAGGG precipitates (Fig 7B and 7C). This latter result is not conflicting with our
interpretation as only a small fraction of telomeres is expected to undergo replication at the
time unit sampled in the experiment [34]. In addition, at least a fraction of the TTAGGG pre-
cipitates obtained from AKTIP-depleted cells at the 4.5, 6 and 9 hrs post-release times might be
a consequence of replication-independent loading of TRF1 on partially/aberrantly replicated
telomeres [35]. Collectively, these results suggest the hypothesis that AKTIP is required for
proper TRF1 association with telomeres during their replication.
AKTIP is enriched at the nuclear periphery
To obtain further insight into the role of AKTIP at telomeres, we examined its subcellular dis-
tribution. Human cells were immunostained with an anti-AKTIP antibody using standard
methods or after protein extraction with Triton X-100, a procedure used to detect subnuclear
localization of proteins [36]. In unextracted cells, AKTIP was found in both the nucleus and
the cytoplasm. In detergent-extracted cells, including HPFs, HeLa and 293T cells, AKTIP was
only nuclear and was enriched near the nuclear rim in a punctate pattern (Fig 8A and 8B). The
AKTIP signal was strongly decreased in shAKTIP cells, confirming the specificity of the anti-
AKTIP Protects Telomeres from Replicative Damage
PLOSGenetics | DOI:10.1371/journal.pgen.1005167 June 25, 2015 12 / 24
Fig 7. AKTIP downregulation impairs telomere replication. Ctr or shAKTIP HeLa cells were synchronized at the G1/S boundary with a double thymidine
block and harvested at the indicated times. (A) Scatter plots showing the proportions of cells in S phase in asynchronous cultures (As) and in cultures
analyzed at various times after release from the double thymidine block. Prior to harvest at each time point, the cells were incubated with BrdU for 30 min. (B)
ChIP analysis on synchronized HeLa cells incubated with BrdU for 1 h before harvesting. Precipitations were performed with an anti-TRF1 antibody. IgG
antibody was used as negative control. Inputs represent 10 and 1% of genomic DNA. Dot-blot analysis was performed using telomeric or ALU repeat-specific
probes. Precipitated DNA was analyzed byWestern blotting with an anti-BrdU antibody. (C, D) Quantification of the data expressed in arbitrary units (A.U.) of
unlabeled (C) or BrdU-labeled (D) precipitated telomeric DNA at the different time points of analysis, each normalized to input samples. The graphs show
three independent experiments, with error bars indicating the SD.
doi:10.1371/journal.pgen.1005167.g007
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AKTIP antibody (Fig 8A). Preferential AKTIP localization at the nuclear periphery was also
detected in 293T cells transfected with an AKTIP-FLAG-expressing vector and stained with an
anti-FLAG antibody (Fig 8A). Examination of optical sections from 50 randomly chosen deter-
gent-extracted cells immunostained for AKTIP did not reveal substantial differences in AKTIP
distribution within the nucleus; AKTIP was consistently enriched at the nuclear periphery in
all cells. This observation suggests that AKTIP does not undergo gross variations in its subnu-
clear localization during the cell cycle.
We next asked whether AKTIP colocalizes with telomeres. Examination of 23 asynchro-
nously growing HPF nuclei stained for both AKTIP and TRF1 (Fig 8C) revealed that the fre-
quency of co-localization of TRF1 and AKTIP signals ranges from 5 to 25%. These results are
consistent with a transient telomere-AKTIP interaction during the S phase.
Discussion
AKTIP is a UEV protein that contains a UBC domain lacking the catalytic cysteine that medi-
ates ubiquitin transfer. Studies on UEV proteins have shown that in many cases their UEV
Fig 8. AKTIP localizes at the nuclear periphery. (A) Immunolocalization of AKTIP in HPFs and HeLa cells with an anti-AKTIP antibody, and in
AKTIP-FLAG expressing 293T cells with an anti-FLAG antibody. shAKTIP HPFs show a strong reduction of the AKTIP signal. (B) Optical sections of a HPF
and a HeLa cell showing AKTIP enrichment at the nuclear periphery. (C) Co-immunostaining of detergent-extracted HPFs for AKTIP and TRF1 (projection of
8 z stacks) showing a limited signal co-localization.
doi:10.1371/journal.pgen.1005167.g008
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domains can bind ubiquitin and play roles in the ubiquitylation-related processes [37]. Howev-
er, UEV proteins serve also functions that that do not appear to be mediated by their UEV do-
mains and that are likely to be unrelated to the ubiquitin pathway. For example, a series studies
on TSG101 (the product of Tumor susceptibility gene 101) has implicated this UEV protein in
diverse cellular functions including cell cycle regulation, endosomal trafficking, transcription,
cytokinesis, and viral budding (reviewed in [38]). Similarly, two studies on AKTIP/Ft1 have
suggested that this protein promotes AKT activity as pro-apoptotic factor [27] and mediates
vesicle trafficking and/or fusion [28].
We have shown that AKTIP is required to prevent spontaneous DNA damage and TIF for-
mation. AKT depletion does not cause DNA repair foci indicating that this kinase is not in-
volved in telomere protection. However, this result does not exclude roles of AKTIP in AKT
regulation and vesicle trafficking. We have further shown that AKTIP interacts with telomeric
DNA and binds the shelterin components TRF1 and TRF2 both in vivo and in vitro. HPFs
with strongly diminished AKTIP levels displayed a strong proliferation defect and arrested in
late S phase showing a substantial reduction in chromatin-bound PCNA. Consistent with these
results, we found that AKTIP physically interacts with both PCNA and RPA70. No substantial
growth defects were observed in immortalized MEFs or human cancer lines treated with Ft1/
AKTIP-interfering lentivectors. However, compared to controls, MEFs showed a strong in-
crease in MTSs, and a more modest increase in STAs, suggesting a defect in telomere replica-
tion. Collectively, these results indicate that AKTIP/Ft1, the mammalian hortologue of
Drosophila peo [20], plays a conserved function required for DNA replication and for telomere
maintenance.
Loss of AKTIP/Ft1 results in fragile telomeres
TIFs and impaired cell proliferation are common phenotypes seen after loss of shelterin com-
ponents or shelterin accessory factors. In contrast, MTSs—or fragile telomeres- have been only
observed after loss of specific telomere factors including TRF1, the BLM and RTEL1 helicases,
the Apollo nuclease, topoisomerase 2α (Top2α), the replisome-associated Timeless protein,
and the components of the mammalian CTC1-STN1-TEN1 (CST) complex (see introduction).
Strong evidence indicates that MTSs are caused by defective telomere replication [6, 17–19],
and single DNAmolecule analysis has shown that in the absence of TRF1 replication forks
tend to stall when they encounter telomeric DNA [6].
Deficiency of proteins involved in telomere replication leads to different telomere-related
phenotypes. Depletion of either TRF1 or BLM results in frequent MTSs but not in telomere
loss; in contrast, lack of Apollo, CST complex or RTEL1 produces both MTSs and telomere
loss [6, 9, 12–16, 19]. In CTC1- or RTEL1-depleted cells, telomere loss is probably due to the
formation of telomeric DNA circles resulting from the excision of the t-loop [13, 18]. It has
been thus proposed that factors like RTEL1 perform two distinct functions: they favor t-loop
disassembly and help unwind G4-DNA structures during telomere replication [13]. TRF1,
BLM and the CST component TEN1 do not appear to prevent t-loop excision [12, 13].
The main telomere aberrations produced by loss of AKTIP/Ft1 are MTSs and STAs; we did
not observe a significant increase in either telomere loss or telomere fusion. Thus, the pheno-
type elicited by loss of AKTIP/Ft1 is very similar to the phenotype observed in TRF1- or BLM-
deficient cells. We have also shown that cells co-depleted of Trf1 and Ft1 exhibit an MTS fre-
quency comparable to that observed in cells depleted of either Trf1 or Ft1 only, suggesting that
both factors function in the same telomere replication pathway. In addition, previous analysis
of cells simultaneously deficient of both TRF1 and BLM revealed an epistatic relationship in
the MTS formation pathway [6]. In contrast, TRF1 and the CST complex appear to function in
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different pathways; co-depletion of TRF1 and STN1 resulted in greater than additive increase
in the MTS frequency relative to those observed in cells depleted of either of these proteins
[19]. Thus, our results suggest that AKTIP/Ft1 works in concert with TRF1 to facilitate telo-
meric DNA replication, while it is not required to prevent t-loop excision.
The role of AKTIP/Ft1 in DNA and telomere replication
Consistent with the cytological data, we showed that AKTIP/Ft1 is required for genome wide
and telomere replication. However, immunostaining of nuclei of asynchronous HPFs revealed
that the frequency of TRF1 spots that co-localize with AKTIP signals ranges from 5 to 25%.
We believe that this low colocalization frequency is in line with our Ch-IP results (Fig 7),
which point to an increased association of AKTIP with telomeres during their replication. Pre-
vious studies have shown that human telomeres replicate throughout the S-phase with telo-
mere-specific time windows, and that individual telomeres can replicate in less than one hour
[34]. Thus, given that the S phase lasts about 6 hours, if AKTIP associated with telomeres only
during their replication, the observed TRF1/AKTIP colocalization frequency would be compat-
ible with the expected one. In summary, our results indicate that Ft1/AKTIP plays a genome-
wide role in DNA replication and is an important component of the molecular machinery that
facilitates mammalian telomere replication.
Our results suggest a simple model for the role of AKTIP/Ft1 in telomere replication. It has
been proposed that TRF1 recruits/activates the BLM and RTEL1 helicases that help unwind G4
DNA structures during TTAGGG repeat replication [6, 13]. Our results suggest the hypothesis
that the AKTIP-TRF1 interaction helps TRF1 to maintain a tight association with telomeric
DNA during its replication. It thus conceivable that AKTIP/Ft1 depletion impairs the interac-
tion of TRF1 and its associated helicases with the telomeric G4 structures compromising the
replication process.
Evolutionary conservation of the AKTIP/Ft1 function
Mammalian telomere proteins have been isolated through the analysis of biochemical interac-
tions between different telomere components, or on the basis of their homology with telomeric
proteins identified in organisms with telomerase such as yeasts. AKTIP/Ft1 is the first mamma-
lian telomere factor isolated because of its homology with a telomeric protein identified in Dro-
sophila, an organism without telomerase in which telomeres are elongated by a transposition-
based mechanism. The rationale for using Drosophila as model system to detect new mammali-
an telomere factors was suggested by recent studies on the organization and evolution of fly
telomeres. Drosophila telomeres are capped by the non-conserved, fast evolving and telomere-
specific terminin complex, which appears to be functionally analogous to shelterin [21–23, 39].
Drosophila telomeres are also protected by a number of conserved “terminin accessory” factors,
which include HP1a, ATM, Mre11, Rad50, Nbs, the E2 enzyme UbcD1, the Woc transcription
factor and Peo [20, 22]. We proposed previously that concomitant with telomerase loss Dro-
sophila rapidly evolved terminin to bind chromosome ends in a sequence-independent fashion,
and that terminin accessory factors did not evolve as rapidly as terminin because of the func-
tional constraints imposed by their involvement in diverse cellular processes [22]. This hypoth-
esis suggests that terminin accessory factors might correspond to ancestral telomere-associated
proteins with homologues in other organisms including mammals. Our results on AKTIP/Ft1
provide a strong support for this idea, showing that the human homologue of the non-terminin
protein Peo is required for telomere maintenance. Strikingly, Peo and AKTIP directly bind ter-
minin and shelterin, respectively, although the proteins that comprise these complexes do not
share any homology. This finding highlights the importance of Peo/AKTIP/Ft1 as telomere
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maintenance factor, as the protein co-evolved with divergent capping complexes to maintain a
direct interaction with telomeres.
Although our hypothesis on Drosophila telomere evolution posits that terminin accessory
factors play conserved telomere-related functions, our results indicate that Peo and AKTIP/Ft1
play similar but non-identical roles in telomere maintenance. Both Peo and AKTIP/Ft1 are re-
quired for DNA replication and for stable PCNA binding to replicating chromatin. However,
while Peo is required to prevent telomere fusion AKTIP/Ft1 does not appear to serve a similar
function. Previous studies identified several other factors (HP1, ATM, Rad50, Mre11 and Nbs)
with major roles in preventing telomere fusion in flies but not in humans (reviewed by [8, 22,
40]). These findings are intriguing and suggest that TF prevention in flies requires more factors
than those that are normally required to avoid mammalian telomere fusion. A possible expla-
nation for this requirement is that the sequence independent Drosophila telomeres, which are
unlikely to form a protective telomere loop, need a more complex capping machinery than
their mammalian counterparts. Regardless of the correctness of this hypothesis, our results on
AKTIP/Ft1 suggest that the identification of additional terminin accessory factors might lead
to the discovery of novel human telomere components.
We have shown that mutations in peo cause TFs that preferentially involve the telomeres as-
sociated with constitutive heterochromatin, providing the first demonstration that subtelo-
meres can affect telomere fusion [20]. Studies on mammalian cells have shown that the
subtelomeric regions affect the telomere replication time [34, 41] but never addressed whether
the fusigenic properties of different chromosome ends depend on subtelomers. Here, we could
not ask this question because AKTIP/Ft1 depletion does not results in TFs. However, we be-
lieve that investigating the role of mammalian subtelomeres in telomere fusion is and interest-
ing research topic that should be addressed by future studies.
Materials and Methods
Cell culture and LV-mediated RNAi
Human foreskin primary fibroblasts (HPFs), p53-/- MEFs [42], HeLa (ATCC CCL-2) and 293T
(ATCC CRL-11268) cells were cultured in DMEM with 10% FBS (Invitrogen). Lentivirus (LV)
production and infection were performed as in [43]; RNAi was carried out using a shRNA vec-
tor (S1 Table), and the pCMV-dR8.74 and pMD2.G vectors (http://www.addgene.org). For all
viruses the transfer vector backbone was PLKO.1 (Sigma). The LV-mediated RNAi efficiency
in all cell types used here remained unchanged for many days post-infection. In the course of
the experiments we consistently performedWestern blotting and/or Q-PCR to assess the level
of AKTIP/Ft1 in RNAi cells. We did not observe substantial variations in these levels in a
27-day period, starting from 24 hours post-infection.
Population doubling (pd) was calculated with the formula Log(nt/n0)x3.33, where n0 is the
number of cells plated and nt the number of cells at the n dpi. Cells were irradiated with 1Gy
(0.28 Gy/min.) of X-rays. Where indicated, cells were treated for 18 h with 2mM hydroxyurea
(Sigma) or 24 h with 1μM aphidicolin (Sigma). AKTIP-FLAG-expressing 293T cells were ob-
tained by transfection of the pCMV6-Entry-AKTIP-FLAG plasmid (OriGene).
Cell synchronization
Cells were synchronized at the G1/S boundary using a double-thymidine block. Cells were
treated with 2 mM thymidine for 14 h, and then released to fresh medium for 10 h followed by
second treatment with 2 mM thymidine for 14 h. In AKTIP-depleted cells, the synchronization
protocol started at 1 dpi.
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FACS analysis
Cells incubated for 30 min in 45 μM BrdU were fixed in 70% cold ethanol for 30 min., washed
in PBS/0.5% Tween 20 and treated with 3M HCl for 45min. Cells were then stained with the
anti-BrdU monoclonal antibody (Dako) and a secondary Alexa-Fluor488-conjugated antibody
(Jackson), and counterstained with Propidium Iodide (PI, Sigma) 20μg/ml. Acquisition was
carried out using a Beckman-Coulter Epics XL flow-cytometer; data were analyzed by the
WinMDI software.
Immunostaining, FISH and cytology
For immunostaining, cells were fixed with 3.7% formaldehyde for 10 min at 4°C and permeabi-
lized with 0.25% Triton X-100 in PBS for 5 min. Where indicated, cells were pre-permeabilized
according to [26]. Cells were then incubated with the following antibodies in the presence of
3% BSA: anti-ATM-pS1981 (Rockland Immunochemicals), anti-53BP1 (Novus Biologicals),
anti-γH2AX (Upstate Biotechnology), anti-AKTIP (Sigma), anti-FLAG (Sigma), anti-TRF1 (a
gift of T. de Lange, Rockefeller University NY), or anti-PCNA (Santa Cruz). Primary antibodies
were detected by 45 min incubation at RT with the following secondary antibodies: anti-
mouse-FITC (Jackson Immunoresearch), anti-mouse-Rhodamine (Jackson Immunoresearch),
anti-rabbit-ALEXA 555 (Invitrogen) or anti-goat-FITC (Jackson Immunoresearch).
Mitotic index was calculated by examination of HPFs incubated for 3 h with colchicine
(Sigma), treated with KCl 75mM for 7min and fixed with methanol: acetic acid 3:1 for 15 min.
Preparations for mitotic index analysis and immunostained preparations were mounted in
DAPI-Vectashield (Vector laboratories) to stain DNA and chromosomes.
FISH was carried out according to [44], and the telomeric probe was obtained by PCR as de-
scribed by [45]. PCR products were then sonicated to obtain 500–2000 bp fragments. After the
hybridization reaction, the slides were washed 3 times in SSC 4X- 0.1% TWEEN-20, air-dried
and then mounted in DAPI-Vectashield.
FISH was examined with a Zeiss Axioplan epifluorescence microscope equipped with a
CCD camera (CoolSnap HQ; Photometrics,). TIFs were detected using a spinning-disk confo-
cal (CarvII, Beckton Dickinson) microscope. Fluorescent optical sections, captured at 1μm Z
steps using the same spinning-disk microscope, were examined separately or as a maximum-
intensity projection.
Q-PCR
Cells were lysed at 7 dpi using the TRIzol reagent (Invitrogen); RNA was prepared according
to the manufacturer's instructions and reverse transcribed using an oligo d(T) primer and
the OMNISCRIPT RT KIT (Qiagen). Target gene expression was quantified according to
[43] using specific primers (S2 Table) selected with the Primer Express software (Applied
Biosystems).
Southern blotting
For each sample, 3μg of DNA extracted from HPFs with Nucleospin Tissue Genomic DNA iso-
lation kit (Clontech) were cleaved with Hinf I/Rsa I (Roche) and separated in a 0.7% agarose
gel. Fractionated DNA was depurinated by treatment with HCl 0.25 M for 20 min, denaturated
with NaCl 1.5M-NaOH 0.5M for 40 min, and neutralized in NaCl 1.5M-TrisHCl 0.5M (ph 7.5)
for 40 min. DNA was then transferred to Nytran-N membrane (Whatman) in 20x SSC by over-
night incubation. The membrane was backed at 80°C for 2 h. Hybridization was carried out
overnight at 47.8°C using a TTAGGG repeat probe obtained according to [45]; membranes
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were then washed with 2X SSC -0.1% SDS at RT and then with 0.2X SSC -0.1% SDS at 50°C.
Telomeric DNA was visualized using the DIG Luminescent detection Kit (Roche) according to
the manufacturer’s instructions.
Immunoblotting
Samples were treated with lysis buffer [Tris–HCl 50mM pH7.4, 10% NP-40, 0.25% NaDesoxy-
cholate, EDTA 1mM, NaCl 150mM, PMSF 1mM, protease inhibitor cocktail (Roche)] and
loaded onto pre-cast 4–12% gradient acrylamide gels (NuPAGE, Invitrogen). After electro-
blotting, filters were incubated with anti-AKTIP (Sigma), anti-TRF2 (Novus Biologicals), anti-
actin-HRP conjugated (Santa Cruz), anti-cyclin A (Santa Cruz), anti-cyclin B (Santa Cruz),
anti-cyclin E (Upstate Biotechnology), anti-p53-pSer15 (Cell Signaling Technology), anti-p53
(DakoCytomation), anti-ATM-pS1981 (Rockland Immunochemicals), anti-ATM (Genetex),
anti-ChK1-PSer345 (Cell Signaling Technology), anti-AKT (Cell Signaling Technology), anti-
PCNA (Santa Cruz), anti-RPA70 (Santa Cruz), or anti-TRF1 (Santa Cruz). Filters were then in-
cubated with appropriate HRP-conjugated secondary antibodies (Santa Cruz), which were de-
tected using the enhanced chemiluminescence system (ECL plus, Amersham). Signals were
quantified with Image J software.
GST-pulldown
Full length AKTIP and AKTIP fragments (Fig 5), were amplified by PCR using the primers
listed in S3 Table and cloned in the pGEX6p1 vector (GE Healthcare) for expression in bacte-
ria. Bacterially expressed GST fusion proteins were purified using QIAGEN Glutathione
HiCap Matrix according to the manufacturer’s instructions. GST pulldown from 293T cell ex-
tracts was carried out as previously described [21]. For the analysis of direct interactions be-
tween bacterially expressed proteins, AKTIP-GST recombinant polypeptides were incubated in
NETN buffer (20 mM Tris-HCl, pH 8, 100 mMNaCl, 1 mM EDTA, 0.5% N P-40) with either
TRF1 or TRF2, produced and purified as previously described [46]. Complexes were collected
by centrifugation, washed 3 times with NETN buffer, and electroblotted as described above.
TRF1 and TRF2 were detected with anti-TRF1 (Santa Cruz) and anti-TRF2 (Imgenex)
antibodies.
ChIP
Cross-linking was carried out by treating HPFs or HeLa cells with 1% formaldehyde for 15
min; the reaction was stopped with 0.125 M glycine. Cells were then lysed, and chromatin was
extracted according to Galati et al. [47]. Chromatin was then incubated overnight with 7.5 μg
of mouse monoclonal anti-AKTIP (Sigma), 1μg of mouse IgG (Sigma), 7μg anti-TRF1 anti-
body (Santa Cruz), or 1μg of goat IgG (Santa Cruz) at 4°C, and ChIP was carried out as de-
scribed [47]. DNA was slot-blotted onto a Hybond N+ and hybridized with a 650 bp telomeric
probe from a plasmid containing a 1.6 Kb of TTAGGG repeats (a gift of E. Gilson), or with an
ALU probe obtained by genomic DNA amplification with the 5’-CGCCTGTAATCCCAGCA
CTTTG-3’ and 5’-ACGCCATTCTCCTGCCTCAGC-3’ oligos. Signals were quantified using
the ImageQuant Software.
For the BrdU-ChIP assay, before cell harvesting at each time point, the cells were incubated
with 20 μM BrdU (Sigma) for 1 h. After dot-blotting and before hybridization with the telo-
meric probe, BrdU incorporation into telomeric DNA was evaluated by western blot analysis
by incubating the membrane with the primary anti-BrdU antibody (Becton Dickinson).
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Bioinformatic analysis of the AKTIP structure
The AKTIP tridimensional model was elaborated following the same procedure used for
the construction of Peo model [20]. Briefly, we used CSI-BLAST and the CLUSTALW
software to obtain a multiple sequence alignment (MSA), which served to construct a
Hidden Markov Model (HMM) of the protein family. Searching the Pfam database with
this HMM yielded the UBC/E2 enzyme family; the second hit was the UEV family that in-
cludes Tsg101, Mms2, UEV1and Peo. AKTIP contains an aspartic acid residue (at position
106, according to SwissProt numbering) in place of the E2 catalytic cysteine. In addition,
8 residues before the site of catalytic cysteine site, AKTIP exhibits an HPL tripeptide (HPH
in Peo) instead of the HPN peptide, which is a canonical signature of the E2 superfamily.
Prediction of potentially disordered regions using the GeneSilico MetaDisorder server re-
vealed that at the N and C termini of AKTIP there are stretches of ~ 70 aa that have a tenden-
cy to be intrinsically disordered. AKTIP modeling was performed using the composite
approach implemented in I-TASSER server [48] and refined using the HAAD software
FG-MD algorithm [49, 50]. The AKTIP model was evaluated a potentially extremely good
model (with a predicted LGscore of 5.9) by the PRO-Q model quality assessment program
[51], and its QMEAN score [52] was 0.8 (the variability range is 0–1, with 1 being a perfect
model).
Supporting Information
S1 Fig. RNAi-mediated AKTIP and Ft1 downregulation. (A, B) AKTIP and Ft1mRNA lev-
els after LV-mediated RNAi. (A) AKTIP expression in HPFs at 7 dpi with ctr or different
shAKTIP constructs (9, 10, 11, 12, and 13). (B) Ft1 expression in p53-/-MEFs at 7 dpi with ctr
or different shFt1 constructs (69, 70 and 73). The control vectors used in HPFs and MEFs con-
tained a shRNA with no targets in human or mouse genome. RNA levels were measured by Q
RT-PCR on total RNA extracts using gene-specific primers. Bars are the mean values ± SD of
samples analyzed in duplicate. (C) Western blots from shAKTIP-11 infected (10 dpi) HPFs,
HeLa and 293T cells, showing a strong reduction in AKTIP expression compared to mock
control.
(TIF)
S2 Fig. Characterization of DNA repair foci observed in AKTIP depleted HPFs. (A) Ex-
amples of DNA repair foci observed after X-irradiation (1 Gy) (B, C) Quantification of
foci containing both γH2AX and 53BP1 (B) or both γH2AX and ATM-P (C), in HPFs in-
fected (5 dpi) with shAKTIP-11, or irradiated (IR; X-ray, 1 Gy). 50 cells examined for each
sample.
(TIF)
S3 Fig. RNAi-mediated AKT downregulation.Western blotting shows reduced AKT expres-
sion in shAKT HPFs (10 dpi) compared to mock and ctr (10 dpi) controls.
(TIF)
S4 Fig. AKTIP depletion does not induce abrupt telomere loss. (A) Frequency of chromatid
ends lacking a FISH signal. Values are the means ± SD of two independent experiments; values
from mock, ctr (7 dpi) and shAKTIP-11 (7 dpi) cells are not significantly different. (B) South-
ern blotting of HinfI/RsaI digested genomic DNA extracted from ctr- or shAKTIP-11-infected
HPFs (13 dpi); telomeric DNA was detected with a TTAGGG repeat probe. Genomic DNA of
late passage (LP, passage 30) untreated HPFs was used as control.
(TIF)
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S5 Fig. RNAi-mediated Ft1 and Trf1 downregulation. Ft1 and Trf1mRNA levels after were
determined at 7 dpi by Q RT-PCR on total RNA extracts using gene-specific primers. Bars are
the mean values ± SD of samples analyzed in duplicate.
(TIF)
S6 Fig. Comparison of the predicted AKTIP and Peo tridimensional models. (A) Alignment
of the amino acid sequence of AKTIP, hUEV1, hUEV2, hUBC13 and Peo. Secondary structure
elements predicted for AKTIP are shown above the alignment. Red and blue arrowheads indi-
cate the sites of the catalytic Cys (Asp in AKTIP) and the HPN motif (HPL in AKTIP), respec-
tively. The red dotted lines indicate predicted intrinsically disordered portions of AKTIP, and
the blue dotted line the disordered region of Peo. (B) Comparison between the Peo and AKTIP
models. The black arrows pointing outwards indicate the starting sites of the predicted disor-
dered regions; AKTIP contains disordered regions of 70 and 60 aa at the N and C-termini, re-
spectively; Peo only contains a disordered region of ~70% aa at its C terminus. These
disordered regions are not represented in the tridimensional molecular models and are shown
in the schematic linear models of the proteins. The variant Asp residues, and the HPL (AKTIP)
and HPH (Peo) motifs are represented as sticks and indicated by red and purple arrows, re-
spectively.
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